INJ Price Prediction Summary • Short-term target (1 week): $3.22 • Medium-term forecast (1 month): $3.44-$3.60 range • Bullish breakout level: $2.93 • Critical INJ Price Prediction Summary • Short-term target (1 week): $3.22 • Medium-term forecast (1 month): $3.44-$3.60 range • Bullish breakout level: $2.93 • Critical

INJ Price Prediction: Targets $3.60 Recovery Despite Technical Weakness

2026/03/09 03:59
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

INJ Price Prediction: Targets $3.60 Recovery Despite Technical Weakness

Luisa Crawford Mar 08, 2026 19:59

INJ Price Prediction Summary • Short-term target (1 week): $3.22 • Medium-term forecast (1 month): $3.44-$3.60 range • Bullish breakout level: $2.93 • Critical support: $2.74 What Crypto Anal...

INJ Price Prediction: Targets $3.60 Recovery Despite Technical Weakness

INJ Price Prediction Summary

• Short-term target (1 week): $3.22 • Medium-term forecast (1 month): $3.44-$3.60 range
• Bullish breakout level: $2.93 • Critical support: $2.74

What Crypto Analysts Are Saying About Injective

Recent analyst coverage from early March provides insight into Injective's potential trajectory. Caroline Bishop projected on March 3rd that "Injective (INJ) trades at $3.03 with neutral RSI and technical consolidation. Analysts project $3.44-$3.60 near-term recovery as INJ approaches key resistance levels."

Rongchai Wang offered a more optimistic outlook on March 4th, stating "INJ trades at $3.10 with neutral RSI at 43.49. Analysts project $3.60-$6.50 recovery potential as Injective approaches key resistance breakout at $3.22."

Tony Kim focused on short-term bounce potential, noting "INJ shows oversold bounce potential from $3.06 support, targeting $3.54 resistance with neutral RSI at 40.89 suggesting possible short-term recovery ahead."

However, these predictions were made when INJ was trading above $3.00, and the token has since declined to $2.84, suggesting market conditions have deteriorated since these forecasts were issued.

INJ Technical Analysis Breakdown

The current technical picture for Injective presents mixed signals with bearish undertones. Trading at $2.84, INJ sits well below all major moving averages, with the 7-day SMA at $2.98 and 20-day SMA at $3.15 acting as immediate resistance barriers.

The RSI reading of 37.44 indicates neutral territory with oversold conditions approaching, which could signal a potential bounce. However, the MACD histogram at 0.0000 shows bearish momentum remains intact, while the extremely low Stochastic readings (%K at 6.02, %D at 4.82) suggest the token is in oversold territory.

Bollinger Band analysis reveals INJ trading near the lower band support at $2.70, with a %B position of 0.1524 indicating the price is much closer to the lower band than the upper band at $3.61. This positioning often precedes either a bounce or a breakdown.

The daily ATR of $0.25 indicates moderate volatility, while the 24-hour trading range of $2.78-$2.88 shows relatively tight price action within a $0.10 range.

Injective Price Targets: Bull vs Bear Case

Bullish Scenario

For an INJ price prediction to turn bullish, the token needs to reclaim the $2.93 strong resistance level, which would confirm a break above the recent trading range. Success here could target the immediate resistance at $3.15 (20-day SMA), followed by the analyst-projected $3.22 breakout level mentioned by Wang.

A sustained move above $3.22 could validate the more optimistic Injective forecast targeting $3.44-$3.60, aligning with Bishop's projections. The ultimate bullish target of $6.50 would require significant fundamental catalysts and broader market support.

Bearish Scenario

The bearish case for this INJ price prediction centers on the failure to hold current support levels. A break below the immediate support at $2.79 could accelerate selling toward the strong support at $2.74.

Given the positioning near the lower Bollinger Band at $2.70, a breakdown could see INJ testing this technical floor. Further deterioration could target the psychologically important $2.50 level, representing a significant decline from current analyst price targets.

Should You Buy INJ? Entry Strategy

Based on current technicals, aggressive buyers might consider accumulating near the $2.74-$2.79 support zone, with a tight stop-loss below $2.70 to limit downside risk. Conservative investors should wait for a clear break and hold above $2.93 before considering entry.

For those following the analyst Injective forecast, scaling into positions between $2.70-$2.85 could provide favorable risk-reward ratios if the $3.44-$3.60 targets materialize. However, position sizing should reflect the high-risk nature of cryptocurrency investments.

A disciplined approach would involve taking partial profits at $3.15 and $3.44 levels while maintaining core positions for the higher targets if momentum continues.

Conclusion

This INJ price prediction suggests cautious optimism despite current technical weakness. While recent analyst forecasts project recovery to $3.44-$6.50, the deterioration from $3.10 to $2.84 indicates these targets may take longer to achieve than initially anticipated.

The oversold technical conditions provide potential for a near-term bounce, but sustainable recovery requires clearing multiple resistance levels. Investors should approach with appropriate risk management and recognize that cryptocurrency price predictions carry inherent uncertainty.

This analysis is for informational purposes only and should not be considered financial advice. Cryptocurrency investments carry significant risk of loss.

Image source: Shutterstock
  • inj price analysis
  • inj price prediction
Market Opportunity
Injective Logo
Injective Price(INJ)
$2.891
$2.891$2.891
+2.91%
USD
Injective (INJ) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

‘Bitcoin Is Going to Die’ – The Latest Death Warning Comes from Oscar-Nominated Actor

‘Bitcoin Is Going to Die’ – The Latest Death Warning Comes from Oscar-Nominated Actor

Terrence Howard said he is not touching BTC as it's going to die.
Share
CryptoPotato2026/03/09 15:15
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Win Big at Shark Secret Casino for Real Cash!

Win Big at Shark Secret Casino for Real Cash!

Cryptsy - Latest Cryptocurrency News and Predictions Cryptsy - Latest Cryptocurrency News and Predictions - Experts in Crypto Casinos Did you know the online gambling
Share
Cryptsy2026/03/09 15:28